Global Rapid Influenza Diagnostic Tests Market 2017-2021

インフルエンザ迅速診断検査の世界市場2017-2021:A型インフルエンザ、B型インフルエンザ

◆タイトル:Global Rapid Influenza Diagnostic Tests Market 2017-2021
◆商品コード:IRTNTR14599
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年8月28日
◆ページ数:74
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:Healthcare and Life Sciences
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、インフルエンザ迅速診断検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、インフルエンザ迅速診断検査の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社はインフルエンザ迅速診断検査の世界市場が2017-2021年期間中に年平均9.06%成長すると予測しています。当レポート上に記載されている主な企業はAlere、BD、Quidel等です。

About Rapid Influenza Diagnostic Tests
RIDT is an antigen-based diagnostic test used for diagnosis of influenza virus infections in point-of-care (POC) settings. It employs lateral flow technique called immunochromatographic assays. RIDTs are available in the market in the form of a dipstick, card, and cassette. The instrument completes the test in less than 30 minutes and is commonly used for the diagnosis of influenza infections. Based on product type, global RIDTs market is segmented into RIDTs for influenza A and RIDTs for influenza B.

Technavio’s analysts forecast the global rapid influenza diagnostic tests market to grow at a CAGR of 9.06% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global rapid influenza diagnostic tests market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of RIDTs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Rapid Influenza Diagnostic Tests Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Alere
• BD
• Quidel

[Other prominent vendors]
• bioMérieux
• CorisBioconcept
• Meridian Bioscience
• Response Biomedical (acquired by OrbiMed)
• Princeton BioMeditech Corporation
• SA Scientific
• Sekisui Diagnostics
• Thermo Fisher Scientific

[Market driver]
• Government initiatives to control and prevent influenza
• For a full, detailed list, view our report

[Market challenge]
• Product safety features of the test kits
• For a full, detailed list, view our report

[Market trend]
• Rising technological advancements in diagnostics
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Market overview
• RIDTs for influenza A
• RIDTs for influenza B

PART 07: Market segmentation by end-user
• Market overview
• Hospitals and diagnostic laboratories
• Academic and research centers
• Homecare

PART 08: Geographical segmentation
• Market overview
• RIDTs market in Americas
• RIDTs market in EMEA
• RIDTs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Rising technological advancements in diagnostics
• Increasing R&D investment

PART 12: Vendor landscape
• Competitive landscape
• Other prominent vendors

PART 13: Key vendor analysis
• Alere
• BD
• Quidel

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global RIDTs market 2016-2021 ($ billions)
Exhibit 02: Five forces analysis
Exhibit 03: Global RIDTs market for influenza A 2016-2021 ($ billions)
Exhibit 04: Global RIDTs market for influenza B 2016-2021 ($ billions)
Exhibit 05: Segmentation of global RIDTs market by end-users 2016 (%)
Exhibit 06: Segmentation of global RIDTs market by end-users 2021 (%)
Exhibit 07: Global RIDTs market for hospitals and diagnostic laboratories 2016-2021 ($ billions)
Exhibit 08: Global RIDTs market for academic and research institutes 2016-2021 ($ billions)
Exhibit 09: Global RIDTs market for homecare 2016-2021 ($ billions)
Exhibit 10: Segmentation of global RIDTs market by geography 2016 (%)
Exhibit 11: Segmentation of global RIDTs market by geography 2021 (%)
Exhibit 12: RIDTs market overview in US
Exhibit 13: RIDTs market in Americas 2016-2021 ($ billions)
Exhibit 14: RIDTs market overview in UK
Exhibit 15: RIDTs market in EMEA 2016-2021 ($ billions)
Exhibit 16: RIDTs market overview in the Japan.
Exhibit 17: RIDTs market in APAC 2016-2021 ($ billions)
Exhibit 18: Factors driving the growth of POCT
Exhibit 19: People who are at high risk of influenza infection
Exhibit 20: Alere: Key highlights
Exhibit 21: Alere: Strength assessment
Exhibit 22: Alere: Strategy assessment
Exhibit 23: Alere: Opportunity assessment
Exhibit 24: BD: Key highlights
Exhibit 25: BD: Strength assessment
Exhibit 26: BD: Strategy assessment
Exhibit 27: BD: Opportunity assessment
Exhibit 28: Quidel: Key highlights
Exhibit 29: Quidel: Strength assessment
Exhibit 30: Quidel: Strategy assessment
Exhibit 31: Quidel: Opportunity assessment



【掲載企業】

Alere, BD, Quidel, bioMérieux, CorisBioconcept, Meridian Bioscience, Response Biomedical, Princeton BioMeditech Corporation, SA Scientific, Sekisui Diagnostics, and Thermo Fisher Scientific.


★調査レポート[インフルエンザ迅速診断検査の世界市場2017-2021:A型インフルエンザ、B型インフルエンザ] (Global Rapid Influenza Diagnostic Tests Market 2017-2021 / IRTNTR14599)販売に関する免責事項
[インフルエンザ迅速診断検査の世界市場2017-2021:A型インフルエンザ、B型インフルエンザ] (Global Rapid Influenza Diagnostic Tests Market 2017-2021 / IRTNTR14599)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆